ESR1 and breast carcinoma: Using the National Cancer Database, we identified patients with pT0–2 ER+/HER2− breast cancer with 3–5 positive LNs who underwent adjuvant chemotherapy, endocrine therapy, and radiation therapy from January 2012 to December 2020.